Aduhelm Blamed for Jump in Next Year’s Medicare Premium
UPDATE: 3 March 2024, 8:22 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
UPDATE: 3 March 2024, 8:22 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Image: Luisa Echevarria at the MALDEF Chicago…
Beta-amyloid plaques are a hallmark of Alzheimer’s, but researchers have long been puzzled about why these plaques can also be found in the brains…
Since the early days of the novel coronavirus pandemic, researchers found that people living with Alzheimer’s were at a higher risk of severe COVID-19…
New clinical trials on memory loss interventions are currently enrolling healthy participants with key Alzhemier’s biomarkers as young as 55 years old. Tau and…
A recent study shows that people with a stronger sense of purpose seem to recall their memories with more vivid details compared to those…
As part of an online conference hosted by the Alzheimer’s Foundation of America, Associate Professor of Medicine at New York University’s (NYU) Long Island…
Despite the absence of disease-modifying treatments, the dementia rate in developed Western countries has actually declined in recent years. In fact, one study showed…
Apathy is an extremely common symptom of Alzheimer’s. It impairs patients’ ability to socialize and maintain routines, activities that are central to preserving their…
Diagnosing degenerative brain diseases early and accurately is a major challenge, and it can take years before a patient receives an accurate diagnosis. But…
You may have read about it in the New York Post: “Scientists pinpoint personality traits that increase risk of Alzheimer’s.” A recent study published in…
Georg Meisl, a research associate at Yusuf Hamied Department of Chemistry, University of Cambridge shares insight into new research that sheds light on just…
Following the approval of the Alzheimer’s drug Aduhelm — and the litany of controversy surrounding it — one question that’s top of mind for…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Image courtesy of Brian Van Buren. Image:…
In the 1980s, when Cindy Weinstein was a graduate student of English, developing her expertise in language and literature, her father Jerry, now deceased,…